Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06251193 · ClinicalTrials.gov registry record · NA

Optimizing CBSST With Executive Function Training for Schizophrenia

A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by University of California, San Diego.

Active
Registry status
NA
Development phase
49
Enrollment target
2
Study locations

NCT06251193 is a NA study of Schizophrenia and Schizoaffective Disorder that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 49 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06251193, a NA study of Schizophrenia and Schizoaffective Disorder, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
49 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research study to test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). The aims include determining whether E-CBSST is feasible and increases Cognitive Behavioral Social Skills Training (CBSST) Skills Learning to a level that will lead to a clinically meaningful improvement in functioning.

Interventions

  • BEHAVIORAL E-CBSST

Study Locations (2)

California

  • UC San Diego - La Jolla

Ontario

  • Centre for Addiction and Mental Health - Toronto

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2024-03-20
Est. Completion 2026-02-10
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT06251193

The ClinicalTrials.gov registry entry for NCT06251193 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (78% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which E-CBSST is the first listed.

NCT06251193 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Ontario.

Frequently Asked Questions

What is clinical trial NCT06251193 about?

NCT06251193 is a clinical study titled "Optimizing CBSST With Executive Function Training for Schizophrenia". The purpose of this research study to test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). The aims include determining whether E-CBSST is feasible and increases Cognitive Behavioral Social Skills Training (CBSST) Skills Learning ...

What is the current status of trial NCT06251193?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 49 participants. The study started on 2024-03-20. Estimated completion is 2026-02-10.

What conditions does trial NCT06251193 study?

This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.

What interventions are being tested in trial NCT06251193?

The interventions under investigation include: E-CBSST (BEHAVIORAL).

Who is sponsoring clinical trial NCT06251193?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06251193 being conducted?

This trial has 2 study locations across California, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.